Aravive, Inc.ARAVNASDAQ
LOADING
|||
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-19.09%
↓ 211% below average
Average (39q)
17.17%
Historical baseline
Range
High:193.09%
Low:-96.91%
CAGR
-0.6%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2023 | -19.09% |
| Q2 2023 | -32.20% |
| Q1 2023 | -11.35% |
| Q4 2022 | -3.84% |
| Q3 2022 | 7.81% |
| Q2 2022 | 33.17% |
| Q1 2022 | 6.63% |
| Q4 2021 | 7.50% |
| Q3 2021 | 39.69% |
| Q2 2021 | 38.00% |
| Q1 2021 | -9.96% |
| Q4 2020 | 28.90% |
| Q3 2020 | 101.03% |
| Q2 2020 | -27.76% |
| Q1 2020 | 39.03% |
| Q4 2019 | -34.61% |
| Q3 2019 | 5.58% |
| Q2 2019 | 27.70% |
| Q1 2019 | -5.38% |
| Q4 2018 | 193.09% |
| Q3 2018 | -70.13% |
| Q2 2018 | -4.50% |
| Q1 2018 | 173.35% |
| Q4 2017 | -96.91% |
| Q3 2017 | 49.11% |
| Q2 2017 | 30.06% |
| Q1 2017 | 31.52% |
| Q4 2016 | -19.03% |
| Q3 2016 | 26.02% |
| Q2 2016 | -9.86% |
| Q1 2016 | 16.71% |
| Q4 2015 | 1.21% |
| Q3 2015 | 28.98% |
| Q2 2015 | -30.18% |
| Q1 2015 | 47.39% |
| Q4 2014 | 10.34% |
| Q3 2014 | 87.03% |
| Q2 2014 | 15.47% |
| Q1 2014 | 40.97% |
| Q4 2013 | -24.52% |